ST Tiansheng announcement, the company held the seventh meeting of the Fifth session of the Board of Directors and the sixth meeting of the Fifth Board of Supervisors on November 22, 2021, which examined and passed the "proposal on the re-employment of the Company's 2021 Audit institutions" and agreed to continue to employ Beijing Xinghua Accounting firm (Special General Partnership) as the company's 2021 audit institution for a period of one year.
The third quarterly report of ST Tiansheng 2021 shows that the company's main income is 602 million yuan, down 33.14% from the same period last year; net profit from home is-67.8365 million yuan, up 43.14% from the same period last year; deducting non-net profit from-85.9833 million yuan, up 30.62% from the same period last year; among them, in the third quarter of 2021, the company's main income in a single quarter was 107 million yuan, down 63.21% from the same period last year; net profit in a single quarter was-27.3568 million yuan, up 46.16% from the same period last year Single-quarter deduction of non-net profit-31.4612 million yuan, up 38.55% over the same period last year; debt ratio 26.18%, investment income 7.1455 million yuan, financial expenses 3.3445 million yuan, gross profit 38.51%.
The stock has no agency rating in the last 90 days. The Securities Star valuation analysis tool shows that ST Tiansheng (002872) good company has a rating of 1.5star, a good price rating of 1.5star, and a comprehensive valuation rating of 1.5star. (rating range: 1-5 stars, up to 5 stars)
The chairman of the company is Liu Shuang. Mr. Liu Shuang: born in September 1993, Chinese nationality, no right of abode abroad, bachelor degree. Mr. Liu Shuang was the head of the Purchasing Department of Tiansheng Pharmaceutical Group Co., Ltd. He is currently the chairman and general manager of Tiansheng Pharmaceutical Group Co., Ltd. Mr. Liu Shuang is also the executive director and general manager of Tiansheng Pharmaceutical Group Chongqing Co., Ltd., Chongqing Weipu Pharmaceutical Co., Ltd., Chongqing Tiansheng Xianming Medical Devices Co., Ltd., Chongqing Bishan Tiansheng Pharmaceutical sales Co., Ltd., Chongqing Ganglong traditional Chinese Medicine Development Co., Ltd., Chongqing Express Trading Co., Ltd., Chongqing Zhongda Medical Technical Service Co., Ltd., Tiansheng Pharmaceutical Group Chongqing Enterprise Management Co., Ltd. He is also a director of Chongqing Tiantong Pharmaceutical Co., Ltd., an executive director of Chongqing Tiantong Pharmaceutical Co., Ltd., and a supervisor of Chongqing Linyu Investment Management Co., Ltd.
This article is compiled by the Securities Star data Center according to the public data and does not constitute investment opinions or suggestions. If you have any questions, please contact us.